Leonard Sank - Director, Oramed Pharmaceuticals Inc

As of March 2, 2021


Leonard Sank Net Worth

  • Net worth is estimated to be at least $4.79M
  • Owns at least 513,888 units of Oramed Pharmaceuticals Inc stock
  • Sold an estimated value of $1.67M in the last 13 years at Oramed Pharmaceuticals Inc

Leonard Sank Trading

  • Largest purchase of shares was 54,517 units , worth over $195.71K on July 18, 2019
  • In total has made about 17 transactions over 13 years
  • Usually trades in January, with the busiest year in 2008
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Leonard Sank Mailing Address

  • Mailing address is 3 Blair Road Cape Town T3 8005 South Africa

Oramed Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Nadav Kidron 2020 $439,076 $220,582 $569,062 $539,131 $1,767,851
Nadav Kidron 2019 $419,460 $224,975 $398,910 $507,750 $1,551,095
Nadav Kidron 2018 $436,310 $148,795 $522,569 $442,326 $1,550,000
Miriam Kidron 2020 $305,840 $70,000 $299,506 $13,354 $688,700
Miriam Kidron 2019 $267,386 $123,149 $211,128 $14,503 $616,166
Miriam Kidron 2018 $273,595 $46,614 $253,204 $13,643 $587,056
Avraham Gabay 2020 $130,554 $15,591 - $44,912 $191,418
Avraham Gabay 2019 $32,122 - $73,928 $9,441 $115,491
Joshua Hexter 2020 $190,801 $12,169 $351,128 $54,735 $608,833
Joshua Hexter 2019 $52,848 - - $9,022 $61,870
Joshua Hexter 2018 $161,002 $26,895 $269,196 $50,505 $507,598
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1176309/000121390021039099/ea144766-def14a_oramedpharma.htm

Oramed Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 21,100 units sold on September 20, 2021 by Kevin Rakin worth over $442.83K
  • In the last 13 years, insiders at Oramed Pharmaceuticals Inc sold an estimated value of $10.81M and bought an estimated value of $6.08M
  • The most active traders are Miriam Kidron, Chief Scientific Officer,  Leonard Sank, Director,  and Nadav Kidron, President and CEO
  • Insider trading is most common in February, with the busiest year in 2014

ORAMED PHARMACEUTICALS INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1